Myeloproliferative Neoplasm, BCR-ABL1 Negative

Myeloproliferative Neoplasm, BCR-ABL1 Negative — Trials · CancerIndex

Clinical trials

Registered studies

333 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 50
Ph III recruiting: 7
Growth YoY: —
Industry share: 41%
Top sponsor: City of Hope Medical Center
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 51–70 of 70 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01193699	Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera(PEGINVERA)	completed	Phase 1 / Phase 2	24	AOP Orphan Pharmaceuticals AGINDUSTRY	1	Jan 30, 2018	clinicaltrials
NCT00795769	Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant	completed	Phase 2	49	Fred Hutchinson Cancer CenterOTHER	1	May 23, 2017	clinicaltrials